$342 Million is the total value of Ghost Tree Capital, LLC's 60 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 61.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | New | ISHARES TRcall | $21,875,000 | – | 100,000 | +100.0% | 6.40% | – |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $19,127,000 | +7.7% | 120,000 | -11.1% | 5.59% | +14.6% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $17,262,000 | +47.4% | 700,000 | +55.6% | 5.05% | +56.8% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $13,767,000 | +44.5% | 255,000 | -10.5% | 4.03% | +53.7% |
| COGT | Sell | COGENT BIOSCIENCES INC | $12,615,000 | -2.8% | 1,500,000 | -6.2% | 3.69% | +3.4% |
| ARVN | Sell | ARVINAS INC | $12,327,000 | -21.9% | 150,000 | -26.8% | 3.60% | -16.9% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $12,071,000 | -23.7% | 790,000 | -7.1% | 3.53% | -18.9% |
| ISEE | IVERIC BIO INC | $11,774,000 | +157.4% | 725,000 | 0.0% | 3.44% | +173.7% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $10,988,000 | -26.9% | 575,000 | -34.3% | 3.21% | -22.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $10,615,000 | +31.4% | 60,000 | +20.0% | 3.10% | +39.8% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $10,462,000 | +89.0% | 350,000 | +180.0% | 3.06% | +101.0% |
| ALLK | New | ALLAKOS INC | $8,999,000 | – | 85,000 | +100.0% | 2.63% | – |
| GHRS | New | GH RESEARCH PLCordinary shares | $8,824,000 | – | 400,000 | +100.0% | 2.58% | – |
| KURA | Sell | KURA ONCOLOGY INC | $7,960,000 | -45.5% | 425,000 | -39.3% | 2.33% | -42.0% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $7,763,000 | -57.2% | 250,000 | -56.1% | 2.27% | -54.4% |
| LPTX | New | LEAP THERAPEUTICS INC | $6,617,000 | – | 1,650,000 | +100.0% | 1.94% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $6,592,000 | – | 200,000 | +100.0% | 1.93% | – |
| BYSI | New | BEYONDSPRING INCcall | $6,304,000 | – | 400,000 | +100.0% | 1.84% | – |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $6,146,000 | -9.6% | 700,000 | +16.7% | 1.80% | -3.9% |
| VRDN | VIRIDIAN THERAPEUTICS INC | $5,758,000 | -10.1% | 350,000 | 0.0% | 1.68% | -4.3% | |
| VTGN | VISTAGEN THERAPEUTICS INC | $5,480,000 | -13.0% | 2,000,000 | 0.0% | 1.60% | -7.5% | |
| AVIR | New | ATEA PHARMACEUTICALS INC | $5,259,000 | – | 150,000 | +100.0% | 1.54% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $5,242,000 | – | 200,000 | +100.0% | 1.53% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $4,950,000 | +12.8% | 275,000 | +10.0% | 1.45% | +19.9% |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $4,944,000 | – | 150,000 | +100.0% | 1.45% | – |
| HLXA | HELIX ACQUISITION CORP | $4,943,000 | -4.5% | 500,000 | 0.0% | 1.44% | +1.5% | |
| CTIC | CTI BIOPHARMA CORP | $4,720,000 | +18.0% | 1,600,000 | 0.0% | 1.38% | +25.5% | |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $4,623,000 | – | 250,000 | +100.0% | 1.35% | – |
| SRRA | SIERRA ONCOLOGY INC | $4,384,000 | +12.6% | 200,000 | 0.0% | 1.28% | +19.8% | |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $4,332,000 | – | 65,000 | +100.0% | 1.27% | – |
| STSA | SATSUMA PHARMACEUTICALS INC | $4,214,000 | -33.9% | 904,225 | 0.0% | 1.23% | -29.7% | |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $4,159,000 | -31.5% | 100,000 | -50.0% | 1.22% | -27.1% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $4,110,000 | -37.2% | 750,000 | -25.0% | 1.20% | -33.1% |
| CBIO | CATALYST BIOSCIENCES INC | $4,110,000 | -5.1% | 1,000,000 | 0.0% | 1.20% | +1.0% | |
| TCRR | New | TCR2 THERAPEUTICS INC | $4,062,000 | – | 477,323 | +100.0% | 1.19% | – |
| PCVX | Buy | VAXCYTE INC | $4,059,000 | +24.4% | 160,000 | +10.3% | 1.19% | +32.3% |
| ALLO | Sell | ALLOGENE THERAPEUTICS INC | $3,855,000 | -46.2% | 150,000 | -45.5% | 1.13% | -42.8% |
| XENE | New | XENON PHARMACEUTICALS INCput | $3,820,000 | – | 250,000 | +100.0% | 1.12% | – |
| TARS | TARSUS PHARMACEUTICALS INC | $3,664,000 | -25.6% | 170,000 | 0.0% | 1.07% | -20.9% | |
| NMTR | New | 9 METERS BIOPHARMA INC | $3,575,000 | – | 2,750,000 | +100.0% | 1.04% | – |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $3,158,000 | -31.1% | 150,000 | -38.3% | 0.92% | -26.8% |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $2,987,000 | – | 100,000 | +100.0% | 0.87% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $2,964,000 | -81.5% | 50,000 | -73.0% | 0.87% | -80.4% |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $2,875,000 | -18.5% | 75,000 | -40.0% | 0.84% | -13.3% |
| FOLD | AMICUS THERAPEUTICS INC | $2,531,000 | -0.9% | 265,000 | 0.0% | 0.74% | +5.4% | |
| BLU | New | BELLUS HEALTH INC NEW | $2,456,000 | – | 400,000 | +100.0% | 0.72% | – |
| IMUX | IMMUNIC INC | $2,345,000 | -27.8% | 265,000 | 0.0% | 0.69% | -23.2% | |
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $2,306,000 | +134.8% | 200,000 | +100.0% | 0.67% | +149.6% |
| MRNA | Buy | MODERNA INC | $2,040,000 | +117.0% | 5,300 | +32.5% | 0.60% | +131.4% |
| ALEC | New | ALECTOR INC | $1,826,000 | – | 80,000 | +100.0% | 0.53% | – |
| IMVT | IMMUNOVANT INCcall | $1,738,000 | -17.8% | 200,000 | 0.0% | 0.51% | -12.6% | |
| MRUS | MERUS N V | $1,650,000 | +4.4% | 75,000 | 0.0% | 0.48% | +11.1% | |
| FULC | New | FULCRUM THERAPEUTICS INC | $1,411,000 | – | 50,000 | +100.0% | 0.41% | – |
| CMRX | CHIMERIX INC | $1,238,000 | -22.6% | 200,000 | 0.0% | 0.36% | -17.7% | |
| CABA | New | CABALETTA BIO INC | $1,216,000 | – | 100,000 | +100.0% | 0.36% | – |
| OTIC | OTONOMY INC | $864,000 | -13.9% | 450,000 | 0.0% | 0.25% | -8.3% | |
| CASI | CASI PHARMACEUTICALS INC | $774,000 | -23.2% | 650,000 | 0.0% | 0.23% | -18.4% | |
| BNTX | New | BIONTECH SEsponsored ads | $546,000 | – | 2,000 | +100.0% | 0.16% | – |
| DNAY | CODEX DNA INC | $390,000 | -49.4% | 35,000 | 0.0% | 0.11% | -46.2% | |
| PRVB | Sell | PROVENTION BIO INC | $320,000 | -62.0% | 50,000 | -50.0% | 0.09% | -59.5% |
| PRVB | Exit | PROVENTION BIO INCput | $0 | – | -150,000 | -100.0% | -0.35% | – |
| ELEV | Exit | ELEVATION ONCOLOGY INC | $0 | – | -100,000 | -100.0% | -0.37% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -75,000 | -100.0% | -0.53% | – |
| CRIS | Exit | CURIS INC | $0 | – | -247,124 | -100.0% | -0.55% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -800,000 | -100.0% | -0.85% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -75,000 | -100.0% | -1.42% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -207,500 | -100.0% | -1.63% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -450,000 | -100.0% | -1.68% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -180,000 | -100.0% | -1.92% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -32,500 | -100.0% | -3.09% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -1,250,000 | -100.0% | -3.33% | – | |
| XBI | Exit | SPDR SER TRcall | $0 | – | -300,000 | -100.0% | -11.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.